<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Korean J Intern Med</journal-id><journal-id journal-id-type="iso-abbrev">Korean J. Intern. Med</journal-id><journal-id journal-id-type="publisher-id">KJIM</journal-id><journal-title-group><journal-title>The Korean Journal of Internal Medicine</journal-title></journal-title-group><issn pub-type="ppub">1226-3303</issn><issn pub-type="epub">2005-6648</issn><publisher><publisher-name>Korean Association of Internal Medicine</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">8268144</article-id><article-id pub-id-type="pmc">4532075</article-id><article-id pub-id-type="doi">10.3904/kjim.1993.8.1.28</article-id><article-id pub-id-type="publisher-id">kjim-8-1-28-6</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Cimetidine Improves the Accuracy of Creatinine Clearance as an Indicator for Glomerular Filtration Rate</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Choi</surname><given-names>Ki Chul</given-names></name><degrees>M.D.</degrees><xref ref-type="corresp" rid="c1-kjim-8-1-28-6"/></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Jongeun</given-names></name><degrees>M.D.</degrees><xref ref-type="aff" rid="af1-kjim-8-1-28-6"><sup>*</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Su Wan</given-names></name><degrees>M.D.</degrees></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Nam Ho</given-names></name><degrees>M.D.</degrees></contrib><contrib contrib-type="author"><name><surname>Moon</surname><given-names>Kyoung Hyup</given-names></name><degrees>M.D.</degrees></contrib><contrib contrib-type="author"><name><surname>Park</surname><given-names>Kwang Ki</given-names></name><degrees>M.D.</degrees></contrib><contrib contrib-type="author"><name><surname>Bom</surname><given-names>Hee Seung</given-names></name><degrees>M.D.</degrees><xref ref-type="aff" rid="af2-kjim-8-1-28-6"><sup>**</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kang</surname><given-names>Young Joon</given-names></name><degrees>M.D.</degrees></contrib></contrib-group><aff id="af1-kjim-8-1-28-6"><label>*</label>Departments of Internal Medicine, Chonnam University Medical School, Kwangju, Korea</aff><aff id="af2-kjim-8-1-28-6"><label>**</label>Physiology and Nuclear Medicine, Chonnam University Medical School, Kwangju, Korea</aff><author-notes><corresp id="c1-kjim-8-1-28-6">Address reprint requests to: Ki Chul Choi, M.D., Department of Internal Medicine, Chonnam University Medical School, 8 Hak-Dong, Kwangju 501-190, Korea</corresp></author-notes><pub-date pub-type="ppub"><month>1</month><year>1993</year></pub-date><volume>8</volume><issue>1</issue><fpage>28</fpage><lpage>33</lpage><permissions><copyright-statement>Copyright &#x000a9; 1993 The Korean Association of Internal Medicine</copyright-statement><copyright-year>1993</copyright-year><license><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Background:</title><p>Although endogenous creatinine clearance is often used as an indicator for the glomerular filtration rate (GFR), it may result in an overestimation due to its tubular secretion. Since cimetidine is known to inhibit tubular secretion of creatinine, it may improve the accuracy of the creatinine clearance in measuring GFR.</p></sec><sec><title>Methods:</title><p>Creatinine clearance (C<sub>cr</sub>) was compared with iothalamate clearance (C<sub>10th</sub>) during oral administration of either placebo or cimetidine in 25 patients with varying degrees of renal dysfunction.</p></sec><sec><title>Results:</title><p>Cimetidine itself had no effect on C<sub>10th</sub> but decreased C<sub>cr</sub>, improving its validity, as measured by a significant decrease of C<sub>cr</sub>/C<sub>10th</sub> from 1.72 during placebo to 1.17 during cimetidine administration. The degree of overestimation measured by the C<sub>cr</sub> was more pronounced in those with more severe renal dysfunction. A significant inverse correlation was noted between C<sub>cr</sub>/C<sub>10th</sub> and GFR. No apparent side effect due to cimetidine was noted.</p></sec><sec><title>Conclusions:</title><p>These results suggest that cimetidine improves the accuracy of C<sub>cr</sub> as an indicator for GFR in patients with varying degrees of renal dysfunction.</p></sec></abstract><kwd-group><kwd>Creatinine clearance</kwd><kwd>Cimetidine</kwd><kwd>Tubular secretion</kwd><kwd>Glomerular filtration rate</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>A great deal of evidence indicates that endogenous creatinine clearance (C<sub>cr</sub>) is inadequate for measuring glomerular filtration rate (GFR) in patients with renal diseases<sup><xref rid="b1-kjim-8-1-28-6" ref-type="bibr">1</xref>&#x02013;<xref rid="b8-kjim-8-1-28-6" ref-type="bibr">8</xref>)</sup>. C<sub>cr</sub> measures GFR with a mean overestimation by 23&#x02013;96%<sup><xref rid="b9-kjim-8-1-28-6" ref-type="bibr">9</xref>&#x02013;<xref rid="b14-kjim-8-1-28-6" ref-type="bibr">14</xref>)</sup>. Furthermore, the degree of overestimation varies greatly from one patient to another and even in the same individual over time<sup><xref rid="b11-kjim-8-1-28-6" ref-type="bibr">11</xref>,<xref rid="b15-kjim-8-1-28-6" ref-type="bibr">15</xref>)</sup>.</p><p>It has been shown that tubular secretion of creatinine increases as renal function decreases, especially in patients with glomerular disorders<sup><xref rid="b8-kjim-8-1-28-6" ref-type="bibr">8</xref>&#x02013;<xref rid="b10-kjim-8-1-28-6" ref-type="bibr">10</xref>)</sup>. The overestimation seen in patients with renal diseases appears to be due to hypersecretion of creatinine by injured renal tubular cells<sup><xref rid="b11-kjim-8-1-28-6" ref-type="bibr">11</xref>,<xref rid="b16-kjim-8-1-28-6" ref-type="bibr">16</xref>)</sup>. To circumvent these problems, while GFR can be measured with the aid of &#x0201c;true filtration markers&#x0201d; such as insulin, iothalamate, diethylenetriaminepenta-acetic acid and ethylenediaminetetra-acetic acid, these are less convenient in handling and more costly than creatinine.</p><p>Secretion of creatinine by the tubular transport system can be inhibited by several anionic and cationic substances<sup><xref rid="b17-kjim-8-1-28-6" ref-type="bibr">17</xref>)</sup>. Among them, cimetidine has been known to reduce secretion of creatinine without impairing GFR, improving the accuracy of C<sub>cr</sub> as a marker for GFR<sup><xref rid="b12-kjim-8-1-28-6" ref-type="bibr">12</xref>,<xref rid="b18-kjim-8-1-28-6" ref-type="bibr">18</xref>,<xref rid="b19-kjim-8-1-28-6" ref-type="bibr">19</xref>)</sup>. However, previous studies simultaneously measured iothalamate clearance (C<sub>10th</sub>), as a standard GFR, and C<sub>cr</sub> during cimetidine treatment. Therefore, it may have not ruled out a possible effect of cimetidine on C<sub>10th</sub>.</p><p>The present study was aimed to investigate the effect of cimetidine on the C<sub>cr</sub>. C<sub>cr</sub> was measured during administration of either placebo or cimetidine. C<sub>10th</sub> was simultaneously determined to serve as standard GFR.</p></sec><sec sec-type="materials|methods"><title>MATERIAL AND METHODS</title><sec><label>1.</label><title>Patient Selection</title><p>The study was performed in 25 patients with varying degrees of renal dysfunction, who were selected from inpatient population at the Division of Nephrology, Chonnam University Hospital. Informed consent was obtained from each patient. C<sub>cr</sub> pre-estimated according to the Cockroft and Gault formulation<sup><xref rid="b20-kjim-8-1-28-6" ref-type="bibr">20</xref>,<xref rid="b21-kjim-8-1-28-6" ref-type="bibr">21</xref>)</sup> less than 10 mL/min was excluded. Other exclusion criteria were pregnancy, use of H<sub>2</sub>-receptor antagonist or antacids, allergy to cimetidine, use of drugs which can influence the metabolism of cimetidine or can interfere with creatinine secretion, and unstable renal function.</p></sec><sec sec-type="methods"><label>2.</label><title>Study Protocols</title><p>The patients were instructed to follow a 3-day schedule to take either placebo or cimetidine. They were supine-positioned throughout and had food and fluid intake every 4 h. The amount of fluid taken was 20 mL/kg, to ensure sufficient flow of urine and to prevent tubular reabsorption of creatinine. Coffee and smoking were not permitted. They were allowed to sleep from 11 : 00 pm to 08 : 00 am.</p><p>The dose of cimetidine was adjusted according to the degree of renal dysfunction in an attempt to achieve approximately equal blood cimetidine levels (<xref ref-type="table" rid="t1-kjim-8-1-28-6">Table 1</xref>). To obtain maximal inhibition on the tubular creatinine secretion, the maximally permitted oral daily dose of 2,000 mg was used in case of normal renal function.</p><p>On Day 1, they were given placebos four or five times. A 24-hour urine was collected through the Foley catheter from 08 : 00 am on Day 1 to 08 : 00 am on Day 2. No clearance measurement was done. On Day 3, 24-hour urine from 08 : 00 am to 08 : 00 am on the next day was collected.</p><p>C<sub>10th</sub> as standard GFR was measured between 10 : 00 am and 2 : 00 pm on Days 1 and 3 using the 24 h urine.</p><p>For the measurement of C<sub>10th</sub>, <sup>125</sup>I-iothalamate was continuously infused (20 <italic>&#x003bc;</italic>Ci/h, for 3 h) following a priming dose of 50 <italic>&#x003bc;</italic>Ci as bolus. Blood samples were obtained from the arm vein opposite to that used for the iothalamate infusion at 90, 120, 150, and 180 min of infusion. Plasma creatinine or <sup>125</sup>I-iothalamate concentrations at the beginning and at the end of each clearance period (30 min) were averaged. Satisfactory urinary output during these periods was maintained by replacing the urinary loss noted in the preceding clearance period with an oral load of water.</p><p><sup>125</sup>I-iothalamate was counted in a gamma scintillation counter (Hewlett Packard, Cobra 5000). Creatinine concentrations were measured by a modified Jaff&#x000e9; reaction in an autoanalyser (Impact 400E). C<sub>10th</sub> was determined by averaging values obtained from three clearance periods. The C<sub>cr</sub> was computed as mL/day and converted into a mL/min.</p><p>Clearances were corrected for the body surface area. C<sub>cr</sub>/C<sub>10th</sub> was calculated to learn to what extent C<sub>cr</sub> overestimates GFR.</p><p>Whole blood counts, liver function tests and analysis of the urinary sediment were done to monitor possible side-effects of cimetidine.</p><p>Data are expressed as means&#x000b1;SD. To compare the renal function parameters during administration of placebo and cimetidine, paired t-test was applied. Linear regression was used to study the relation between C<sub>cr</sub>/C<sub>10th</sub> and GFR. A P-value smaller than 0.05 was considered statistically significant.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>The subjects (12 men, 13 women) aged 41&#x02013;23 years ranging between 18 and 65. Their types of renal disorders were chronic glomerulonephritis (4 cases), diabetic nephropathy (4 cases), nephrotic syndrome (3 cases), autosomal dominant polycystic kidney disease (2 cases), hypertensive nephrosclerosis (1 case), lupus nephritis(1 case), miscellaneous causes (2 cases) and unknown (4 cases).</p><p>Cimetidine had no effect on GFR measured as C<sub>10th</sub>, being 44&#x000b1;27 and 44&#x000b1;29 mL/min/1.73m<sup>2</sup>, during the placebo and during cimetidine treatment, respectively (<xref ref-type="table" rid="t2-kjim-8-1-28-6">Table 2</xref>). However, cimetidine resulted in a significant decrease of C<sub>cr</sub>, from 69&#x000b1;36 during the placebo to 50&#x000b1;31 mL/min/1.73m<sup>2</sup> during the cimetidine. The difference between C<sub>cr</sub> and C<sub>10th</sub> decreased from 24&#x000b1;16 to 5&#x000b1;4 mL/min/1.73m<sup>2</sup>.</p><p>C<sub>cr</sub>/C<sub>10th</sub> also significantly decreased from 1.72&#x000b1;0.51 to 1.17&#x000b1;0.20, indicating an improvement in validity (<xref ref-type="fig" rid="f1-kjim-8-1-28-6">Fig. 1</xref>). When the patients were classified into three groups, according to their renal function as measured by C<sub>10th</sub>, C<sub>cr</sub>/C<sub>10th</sub> was larger in those with more severe renal dysfunction, indicating a more pronounced overestimation of GFR (<xref ref-type="table" rid="t3-kjim-8-1-28-6">Table 3</xref>). A significant inverse relation was noted between C<sub>cr</sub>/C<sub>10th</sub> and GFR (<xref ref-type="fig" rid="f2-kjim-8-1-28-6">Fig. 2</xref>).</p><p>C<sub>cr</sub> and C<sub>10th</sub> disagreed during the placebo treatment, which was improved by the cimetidine treatment (<xref ref-type="fig" rid="f3-kjim-8-1-28-6">Fig. 3</xref>). No patient reported any side effect due to cimetidine.</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>C<sub>cr</sub> in 25 patients with renal diseases overestimated GFR by 72%, being similar to those reported in the previous studies<sup><xref rid="b4-kjim-8-1-28-6" ref-type="bibr">4</xref>,<xref rid="b9-kjim-8-1-28-6" ref-type="bibr">9</xref>)</sup>. In addition, the degree of overestimation was larger in those with more severe renal dysfunction. A significant inverse correlation noted between C<sub>cr</sub>/C<sub>10th</sub> and GFR, as has been shown in the previous studies<sup><xref rid="b1-kjim-8-1-28-6" ref-type="bibr">1</xref>,<xref rid="b10-kjim-8-1-28-6" ref-type="bibr">10</xref>)</sup>, suggests that the degree of overestimation is associated with the degree of renal functional impairment.</p><p>Creatinine and cimetidine are secreted by the organic cation secretary system<sup><xref rid="b22-kjim-8-1-28-6" ref-type="bibr">22</xref>)</sup>. The reduction of tubular creatinine secretion due to cimetidine is assumed to result from competitive inhibition on the common transport system in the proximal tubule, cimetidine having a higher affinity than creatinine for the carrier at the luminal membrane<sup><xref rid="b23-kjim-8-1-28-6" ref-type="bibr">23</xref>)</sup>.</p><p>Cimetidine only incompletely reduced the tubular creatinine secretion. Previous studies<sup><xref rid="b19-kjim-8-1-28-6" ref-type="bibr">19</xref>,<xref rid="b24-kjim-8-1-28-6" ref-type="bibr">24</xref>)</sup> reported that patients with incomplete inhibition had a larger cimetidine clearance, along with lower plasma cimetidine concentration and cimetidine/creatinine ratio, than did those with complete inhibition<sup><xref rid="b19-kjim-8-1-28-6" ref-type="bibr">19</xref>)</sup>. This ratio is important, in that certain plasma ratio of unbound competitive compounds is necessary to induce complete inhibition<sup><xref rid="b25-kjim-8-1-28-6" ref-type="bibr">25</xref>)</sup>. Taken together, it may be recommended that a maximal permitted dose of cimetidine should be used to make the validity of C<sub>cr</sub> better.</p><p>In the previous studies<sup><xref rid="b1-kjim-8-1-28-6" ref-type="bibr">1</xref>,<xref rid="b12-kjim-8-1-28-6" ref-type="bibr">12</xref>,<xref rid="b18-kjim-8-1-28-6" ref-type="bibr">18</xref>,<xref rid="b19-kjim-8-1-28-6" ref-type="bibr">19</xref>,<xref rid="b26-kjim-8-1-28-6" ref-type="bibr">26</xref>,<xref rid="b27-kjim-8-1-28-6" ref-type="bibr">27</xref>)</sup>, C<sub>cr</sub>/C<sub>10th</sub> after administration of cimetidine varied from 0.89 to 1.35. The variation may be related to different dosage schedules and routes of administration of cimetidine. In addition, the fall of C<sub>cr</sub>/C<sub>10th</sub> below 1.0<sup><xref rid="b26-kjim-8-1-28-6" ref-type="bibr">26</xref>)</sup> raises the question whether tubular reabsorption of creatinine might exist. Although tubular reabsorption of creatinine has been reported in rats<sup><xref rid="b28-kjim-8-1-28-6" ref-type="bibr">28</xref>)</sup>, evidence is lacking in humans.</p><p>On the other hand, no serious adverse effects due to cimetidine were noted, which may be of special importance where cimetidine is used for a non-therapeutic purpose. In a recent meta-analysis of randomized clinical trials with cimetidine, the adverse effect was negligible even with the dosage as high as 2,000 mg/day<sup><xref rid="b29-kjim-8-1-28-6" ref-type="bibr">29</xref>)</sup>.</p><p>The cimetidine-aided creatinine clearance can be promoted as a convenient and inexpensive as well as an exact measure of GFR. It may replace classical measurement of GFR with a true filtration marker as this is more expensive and less convenient, especially for the long-term follow-up studies of renal function<sup><xref rid="b30-kjim-8-1-28-6" ref-type="bibr">30</xref>)</sup>. Moreover, monitoring the progress of renal deterioration by plotting the reciprocal values of serum creatinine against time<sup><xref rid="b31-kjim-8-1-28-6" ref-type="bibr">31</xref>)</sup> might become more reliable by the use of cimetidine. Finally, cimetidine may improve the sensitivity of serum creatinine in detecting minimal changes in renal function by restoring the inverse relationship between serum creatinine and GFR, which is actually blunted by the increase of tubular secretion and reduction of GFR<sup><xref rid="b1-kjim-8-1-28-6" ref-type="bibr">1</xref>)</sup>.</p><p>In summary, our results show that oral administration of cimetidine improves the accuracy of C<sub>cr</sub> as a marker for GFR.</p></sec></body><back><fn-group><fn id="fn1-kjim-8-1-28-6" fn-type="supported-by"><p>This work was supported by Clinical Research Grant (1992) of Chonnam University Hospital</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="b1-kjim-8-1-28-6"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shemesh</surname><given-names>O</given-names></name><name><surname>Golbetz</surname><given-names>H</given-names></name><name><surname>Kriss</surname><given-names>JP</given-names></name><name><surname>Myers</surname><given-names>BD</given-names></name></person-group><article-title>Limitations of creatinine as a filtration marker in glomerulopathic patients</article-title><source>Kidney int</source><volume>28</volume><fpage>830</fpage><year>1985</year><pub-id pub-id-type="pmid">2418254</pub-id></element-citation></ref><ref id="b2-kjim-8-1-28-6"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>AS</given-names></name></person-group><article-title>Measurement of renal function in chronic renal disease</article-title><source>Kidney Int</source><volume>38</volume><fpage>167</fpage><year>1990</year><pub-id pub-id-type="pmid">2200925</pub-id></element-citation></ref><ref id="b3-kjim-8-1-28-6"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lew</surname><given-names>SR</given-names></name><name><surname>Bosch</surname><given-names>JP</given-names></name></person-group><article-title>Effect of diet on creatinine clearance and excretion in young and elderly healthy subjects and in patients with renal disease</article-title><source>J Am Soc Nephrol</source><volume>2</volume><fpage>856</fpage><year>1991</year><pub-id pub-id-type="pmid">1751789</pub-id></element-citation></ref><ref id="b4-kjim-8-1-28-6"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeSanto</surname><given-names>NG</given-names></name><name><surname>Coppola</surname><given-names>S</given-names></name><name><surname>Anastasio</surname><given-names>P</given-names></name><name><surname>Coscarella</surname><given-names>G</given-names></name><name><surname>Capasso</surname><given-names>G</given-names></name><name><surname>Bellini</surname><given-names>L</given-names></name><name><surname>Santangelo</surname><given-names>R</given-names></name><name><surname>Massino</surname><given-names>L</given-names></name><name><surname>Siciliano</surname><given-names>A</given-names></name></person-group><article-title>Predicted creatinine clearance to assess glomerular filtration rate in chronic renal disease in humans</article-title><source>Am J Nephrol</source><volume>11</volume><fpage>181</fpage><year>1991</year><pub-id pub-id-type="pmid">1962664</pub-id></element-citation></ref><ref id="b5-kjim-8-1-28-6"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicoll</surname><given-names>SR</given-names></name><name><surname>Sainsbury</surname><given-names>R</given-names></name><name><surname>Bailey</surname><given-names>RR</given-names></name><name><surname>King</surname><given-names>A</given-names></name><name><surname>Frampton</surname><given-names>C</given-names></name><name><surname>Elliot</surname><given-names>JR</given-names></name><name><surname>Turner</surname><given-names>JG</given-names></name></person-group><article-title>Assessment of creatinine clearance in healthy subjects over 65 years of age</article-title><source>Nephron</source><volume>51</volume><fpage>621</fpage><year>1991</year><pub-id pub-id-type="pmid">1766502</pub-id></element-citation></ref><ref id="b6-kjim-8-1-28-6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomlanovich</surname><given-names>S</given-names></name><name><surname>Golbetz</surname><given-names>H</given-names></name><name><surname>Perlroth</surname><given-names>M</given-names></name><name><surname>Stinson</surname><given-names>E</given-names></name><name><surname>Myers</surname><given-names>BD</given-names></name></person-group><article-title>Limitations of creatinine in quantifying the severity of cyclosporine-induced chronic nephropathy</article-title><source>Am J Kidney Dis</source><volume>8</volume><fpage>332</fpage><year>1986</year><pub-id pub-id-type="pmid">3538857</pub-id></element-citation></ref><ref id="b7-kjim-8-1-28-6"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubovsky</surname><given-names>EV</given-names></name><name><surname>Russell</surname><given-names>CD</given-names></name></person-group><article-title>Quantitation of renal function with glomerular and tubular agents</article-title><source>Sem Nucl Med</source><volume>12</volume><fpage>308</fpage><year>1982</year></element-citation></ref><ref id="b8-kjim-8-1-28-6"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berlyne</surname><given-names>GM</given-names></name><name><surname>Varley</surname><given-names>H</given-names></name><name><surname>Nilwarangkur</surname><given-names>S</given-names></name><name><surname>Hoerni</surname><given-names>M</given-names></name></person-group><article-title>Endogenous creatinine clearance and glomerular filtration rate</article-title><source>Lancet</source><volume>ii</volume><fpage>874</fpage><year>1964</year><pub-id pub-id-type="pmid">14197181</pub-id></element-citation></ref><ref id="b9-kjim-8-1-28-6"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carrie</surname><given-names>BJ</given-names></name><name><surname>Golbetz</surname><given-names>HV</given-names></name><name><surname>Michales</surname><given-names>AS</given-names></name><name><surname>Myers</surname><given-names>BD</given-names></name></person-group><article-title>Creatinine: An inadequate filtration marker in glomerular disease</article-title><source>Am J Med</source><volume>69</volume><fpage>177</fpage><year>1980</year><pub-id pub-id-type="pmid">6157324</pub-id></element-citation></ref><ref id="b10-kjim-8-1-28-6"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bauer</surname><given-names>JH</given-names></name><name><surname>Brooks</surname><given-names>CS</given-names></name><name><surname>Burch</surname><given-names>RN</given-names></name></person-group><article-title>Clinical appraisal of creatinine clearance as a measurement of glomerular filtration rate</article-title><source>Am J Kidney Dis</source><volume>2</volume><fpage>337</fpage><year>1982</year><pub-id pub-id-type="pmid">7148824</pub-id></element-citation></ref><ref id="b11-kjim-8-1-28-6"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petri</surname><given-names>M</given-names></name><name><surname>Bockenstedt</surname><given-names>L</given-names></name><name><surname>Colman</surname><given-names>J</given-names></name><name><surname>Whiting-O&#x02019; Keefe</surname><given-names>Q</given-names></name><name><surname>Fitz</surname><given-names>G</given-names></name><name><surname>Sebustian</surname><given-names>A</given-names></name><name><surname>Heilman</surname><given-names>D</given-names></name></person-group><article-title>Serial assessment of glomerular filtration rate in lupus nephropathy</article-title><source>Kidney Int</source><volume>34</volume><fpage>832</fpage><year>1988</year><pub-id pub-id-type="pmid">3210545</pub-id></element-citation></ref><ref id="b12-kjim-8-1-28-6"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hilbrands</surname><given-names>LB</given-names></name><name><surname>Artz</surname><given-names>MA</given-names></name><name><surname>Wetzels</surname><given-names>JFM</given-names></name><name><surname>Koene</surname><given-names>RAP</given-names></name></person-group><article-title>Cimetidine improves the reliability of creatinine as a marker of glomerular filtration</article-title><source>Kidney Int</source><volume>40</volume><fpage>1171</fpage><year>1991</year><pub-id pub-id-type="pmid">1762320</pub-id></element-citation></ref><ref id="b13-kjim-8-1-28-6"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berlyne</surname><given-names>GM</given-names></name></person-group><article-title>Endogenous creatinine clearance and the glomerular filtration rate</article-title><source>Am Heart J</source><volume>70</volume><fpage>143</fpage><year>1965</year><pub-id pub-id-type="pmid">14314179</pub-id></element-citation></ref><ref id="b14-kjim-8-1-28-6"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sawyer</surname><given-names>WT</given-names></name><name><surname>Canaday</surname><given-names>BR</given-names></name><name><surname>Poe</surname><given-names>TE</given-names></name></person-group><article-title>A multicenter evaluation of variables affecting the predictability of creatinine clearance</article-title><source>Am J Clin Pathol</source><volume>78</volume><fpage>832</fpage><year>1982</year><pub-id pub-id-type="pmid">7148749</pub-id></element-citation></ref><ref id="b15-kjim-8-1-28-6"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papadakis</surname><given-names>MA</given-names></name><name><surname>Arieff</surname><given-names>AI</given-names></name></person-group><article-title>Unpredictability of clinical evaluation of renal function in cirrhosis. Prospective study</article-title><source>Am J Med</source><volume>82</volume><fpage>945</fpage><year>1987</year><pub-id pub-id-type="pmid">3578363</pub-id></element-citation></ref><ref id="b16-kjim-8-1-28-6"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>AS</given-names></name><name><surname>Perrone</surname><given-names>RD</given-names></name><name><surname>Madias</surname><given-names>NE</given-names></name></person-group><article-title>Serum creatinine and renal function</article-title><source>Ann Rev Med</source><volume>39</volume><fpage>465</fpage><year>1988</year><pub-id pub-id-type="pmid">3285786</pub-id></element-citation></ref><ref id="b17-kjim-8-1-28-6"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wetzels</surname><given-names>JFM</given-names></name><name><surname>Huysmans</surname><given-names>FTHM</given-names></name><name><surname>Koene</surname><given-names>RAP</given-names></name></person-group><article-title>Creatinine as a marker of glomerular filtration rate</article-title><source>Neth J Med</source><volume>33</volume><fpage>144</fpage><year>1988</year><pub-id pub-id-type="pmid">3067097</pub-id></element-citation></ref><ref id="b18-kjim-8-1-28-6"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roubenoff</surname><given-names>R</given-names></name><name><surname>Drew</surname><given-names>H</given-names></name><name><surname>Moyer</surname><given-names>M</given-names></name><name><surname>Petri</surname><given-names>M</given-names></name><name><surname>Whiting-O&#x02019;Keefe</surname><given-names>Q</given-names></name><name><surname>Heilman</surname><given-names>D</given-names></name></person-group><article-title>Oral cimetidine improves the accuracy and precision of creatinine clearance in lupus nephritis</article-title><source>Ann Int Med</source><volume>113</volume><fpage>501</fpage><year>1990</year><pub-id pub-id-type="pmid">2393206</pub-id></element-citation></ref><ref id="b19-kjim-8-1-28-6"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Acker</surname><given-names>BAC</given-names></name><name><surname>Koomen</surname><given-names>GC</given-names></name><name><surname>Koopman</surname><given-names>MG</given-names></name><name><surname>de Waart</surname><given-names>DR</given-names></name><name><surname>Arisz</surname><given-names>L</given-names></name></person-group><article-title>Creatinine clearance during cimetidine administration for measurement of glomerular filtration rate</article-title><source>Lancet</source><volume>340</volume><fpage>1326</fpage><year>1992</year><pub-id pub-id-type="pmid">1360044</pub-id></element-citation></ref><ref id="b20-kjim-8-1-28-6"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cockcroft</surname><given-names>DW</given-names></name><name><surname>Gault</surname><given-names>MH</given-names></name></person-group><article-title>Prediction of creatinine clearance from serum creatinine</article-title><source>Nephron</source><volume>16</volume><fpage>31</fpage><year>1976</year><pub-id pub-id-type="pmid">1244564</pub-id></element-citation></ref><ref id="b21-kjim-8-1-28-6"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gault</surname><given-names>MH</given-names></name><name><surname>Longerich</surname><given-names>LL</given-names></name><name><surname>Harnett</surname><given-names>JD</given-names></name><name><surname>Wesolowski</surname><given-names>C</given-names></name></person-group><article-title>Predicting glomerular function from adjusted serum creatinine</article-title><source>Nephron</source><volume>62</volume><fpage>249</fpage><year>1992</year><pub-id pub-id-type="pmid">1436333</pub-id></element-citation></ref><ref id="b22-kjim-8-1-28-6"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Ginneken</surname><given-names>CAM</given-names></name><name><surname>Russel</surname><given-names>FGM</given-names></name></person-group><article-title>Saturable pharmacokinetics in the renal excretion of dogs</article-title><source>Clin Pharmacokinet</source><volume>16</volume><fpage>38</fpage><year>1989</year><pub-id pub-id-type="pmid">2650954</pub-id></element-citation></ref><ref id="b23-kjim-8-1-28-6"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gisclon</surname><given-names>LG</given-names></name><name><surname>Giacomini</surname><given-names>KM</given-names></name></person-group><article-title>Inhibtion of cimetidine transport by creatinine in luminal membrane vesicles prepared from rabbit kidney</article-title><source>Drug Metab Disp</source><volume>16</volume><fpage>331</fpage><year>1988</year></element-citation></ref><ref id="b24-kjim-8-1-28-6"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Somogyi</surname><given-names>A</given-names></name><name><surname>Gugler</surname><given-names>R</given-names></name></person-group><article-title>Clinical pharmacokinetics of cimetidine</article-title><source>Clin Pharmacokinet</source><volume>8</volume><fpage>463</fpage><year>1983</year><pub-id pub-id-type="pmid">6418428</pub-id></element-citation></ref><ref id="b25-kjim-8-1-28-6"><label>25.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Brater</surname><given-names>C</given-names></name><name><surname>Sokol</surname><given-names>PP</given-names></name><name><surname>Halls</surname><given-names>SD</given-names></name><name><surname>McKinney</surname><given-names>TD</given-names></name></person-group><article-title>Renal elimination for drugs: methods and determinants</article-title><person-group person-group-type="editor"><name><surname>Seldin</surname><given-names>DW</given-names></name><name><surname>Giebisch</surname></name></person-group><source>The Kidney: Physiology and Pathophysiology</source><edition>2nd ed</edition><fpage>3597</fpage><publisher-loc>New York</publisher-loc><publisher-name>Raven Press</publisher-name><year>1992</year></element-citation></ref><ref id="b26-kjim-8-1-28-6"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larsson</surname><given-names>R</given-names></name><name><surname>Bodemar</surname><given-names>G</given-names></name><name><surname>Kagedal</surname><given-names>B</given-names></name><name><surname>Walan</surname><given-names>A</given-names></name></person-group><article-title>The effects of cimetidine (Tagamet<sup>R</sup>) on renal function in patients with renal failure</article-title><source>Acta Med Scand</source><volume>208</volume><fpage>27</fpage><year>1980</year><pub-id pub-id-type="pmid">7001858</pub-id></element-citation></ref><ref id="b27-kjim-8-1-28-6"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burgess</surname><given-names>E</given-names></name><name><surname>Blair</surname><given-names>A</given-names></name><name><surname>Krichman</surname><given-names>K</given-names></name><name><surname>Cutler</surname><given-names>RE</given-names></name></person-group><article-title>Inhibition of renal creatinine secretion by cimetidine in humans</article-title><source>Renal Physiol</source><volume>5</volume><fpage>27</fpage><year>1987</year><pub-id pub-id-type="pmid">7079556</pub-id></element-citation></ref><ref id="b28-kjim-8-1-28-6"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Namnum</surname><given-names>P</given-names></name><name><surname>Insogna</surname><given-names>K</given-names></name><name><surname>Baggish</surname><given-names>D</given-names></name><name><surname>Hayslett</surname><given-names>JP</given-names></name></person-group><article-title>Evidence for bidirectional net movement of creatinine in rat kidney</article-title><source>Am J Physiol</source><volume>244</volume><fpage>F719</fpage><year>1983</year><pub-id pub-id-type="pmid">6859263</pub-id></element-citation></ref><ref id="b29-kjim-8-1-28-6"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richter</surname><given-names>JM</given-names></name><name><surname>Colditz</surname><given-names>GA</given-names></name><name><surname>Huse</surname><given-names>DM</given-names></name><name><surname>Delea</surname><given-names>TE</given-names></name><name><surname>Oster</surname><given-names>G</given-names></name></person-group><article-title>Cimetidine and adverse reactions: A meta-analysis of randomized clinical trials of short-term therapy</article-title><source>Am J Med</source><volume>87</volume><fpage>278</fpage><year>1989</year><pub-id pub-id-type="pmid">2773966</pub-id></element-citation></ref><ref id="b30-kjim-8-1-28-6"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosman</surname><given-names>JB</given-names></name><name><surname>Meyer</surname><given-names>S</given-names></name><name><surname>Ter Wee</surname><given-names>PM</given-names></name><name><surname>Piers-Becht</surname><given-names>TPHM</given-names></name><name><surname>Sluiter</surname><given-names>WJ</given-names></name><name><surname>Donker</surname><given-names>AJM</given-names></name></person-group><article-title>Prospective randomized trial of early dietary protein restriction in chronic renal failure</article-title><source>Lancet</source><volume>ii</volume><fpage>1291</fpage><year>1984</year><pub-id pub-id-type="pmid">6150320</pub-id></element-citation></ref><ref id="b31-kjim-8-1-28-6"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitch</surname><given-names>WE</given-names></name><name><surname>Walser</surname><given-names>M</given-names></name><name><surname>Buffington</surname><given-names>GA</given-names></name><name><surname>Lemann</surname><given-names>J</given-names><suffix>Jr</suffix></name></person-group><article-title>A simple method of estimating progression of chronic renal failure</article-title><source>Lancet</source><volume>ii</volume><fpage>1326</fpage><year>1976</year><pub-id pub-id-type="pmid">63803</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="f1-kjim-8-1-28-6" orientation="portrait" position="float"><label>Fig. 1.</label><caption><p>C<sub>cr</sub>/C<sub>10th</sub> during placebo and cimetidine administration. (<sup>*</sup>p&#x0003c;0.001)</p></caption><graphic xlink:href="kjim-8-1-28-6f1"/></fig><fig id="f2-kjim-8-1-28-6" orientation="portrait" position="float"><label>Fig. 2.</label><caption><p>C<sub>cr</sub>/C<sub>10th</sub> vs. C<sub>10th</sub> during administration of cimetidine.</p></caption><graphic xlink:href="kjim-8-1-28-6f2"/></fig><fig id="f3-kjim-8-1-28-6" orientation="portrait" position="float"><label>Fig. 3.</label><caption><p>Differences between C<sub>cr</sub> and C<sub>10th</sub> vs. GFR determined by averaging C<sub>cr</sub> and C<sub>10th</sub>.</p></caption><graphic xlink:href="kjim-8-1-28-6f3"/></fig><table-wrap id="t1-kjim-8-1-28-6" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Daily Doses of Cimetidine for Different Levels of Renal Function</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="top" rowspan="1" colspan="1">C<sub>cr</sub><italic><xref ref-type="table-fn" rid="tfn1-kjim-8-1-28-6"><sup>a</sup></xref></italic> (mL/min /1.73 m<sup>2</sup>)</th><th align="center" valign="top" rowspan="1" colspan="1">Doses on Days 2 and 3<italic><xref ref-type="table-fn" rid="tfn2-kjim-8-1-28-6"><sup>b</sup></xref></italic> (mg)</th><th align="center" valign="top" rowspan="1" colspan="1">Last morning dose (mg)</th></tr></thead><tbody><tr><td align="right" valign="top" rowspan="1" colspan="1">&#x0003e;75</td><td align="center" valign="top" rowspan="1" colspan="1">400&#x02013;400&#x02013;400&#x02013;800</td><td align="center" valign="top" rowspan="1" colspan="1">800</td></tr><tr><td align="right" valign="top" rowspan="1" colspan="1">50&#x0223c;75</td><td align="center" valign="top" rowspan="1" colspan="1">400&#x02013;400&#x02013;400&#x02013;400</td><td align="center" valign="top" rowspan="1" colspan="1">600</td></tr><tr><td align="right" valign="top" rowspan="1" colspan="1">30&#x0223c;50</td><td align="center" valign="top" rowspan="1" colspan="1">400&#x02013;400&#x02013;600</td><td align="center" valign="top" rowspan="1" colspan="1">600</td></tr><tr><td align="right" valign="top" rowspan="1" colspan="1">20&#x0223c;30</td><td align="center" valign="top" rowspan="1" colspan="1">400&#x02013;400&#x02013;400</td><td align="center" valign="top" rowspan="1" colspan="1">400</td></tr></tbody></table><table-wrap-foot><fn id="tfn1-kjim-8-1-28-6"><label>a</label><p>C<sub>cr</sub>, endogenous creatinine clearance pre-estimated according to the Cockroft-Gault equation.</p></fn><fn id="tfn2-kjim-8-1-28-6"><label>b</label><p>The first dose was given on waking up, the last dose at bedtime, and interjacent 2&#x02013;3 doses at regular intervals.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t2-kjim-8-1-28-6" orientation="portrait" position="float"><label>Table 2.</label><caption><p>Creatinine Clearance (C<sub>cr</sub>), Iothalamate Clearance (C<sub>10th</sub>) and Ratio of C<sub>cr</sub> to C<sub>10th</sub> During Placebo and Cimetidine Administration</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" rowspan="5" colspan="1">Patient</th><th align="center" valign="middle" rowspan="1" colspan="1"/><th align="center" valign="middle" rowspan="1" colspan="1">Placebo</th><th align="center" valign="middle" rowspan="5" colspan="1">C<sub>cr</sub>/C<sub>10th</sub></th><th align="center" valign="middle" rowspan="1" colspan="1"/><th align="center" valign="middle" rowspan="1" colspan="1">Cimetidine</th><th align="center" valign="middle" rowspan="5" colspan="1">C<sub>cr</sub>/C<sub>10th</sub></th></tr><tr><th colspan="2" align="center" valign="middle" rowspan="1">
<hr/></th><th colspan="2" align="center" valign="middle" rowspan="1">
<hr/></th></tr><tr><th align="center" valign="middle" rowspan="1" colspan="1">C<sub>cr</sub></th><th align="center" valign="middle" rowspan="1" colspan="1">C<sub>10th</sub></th><th align="center" valign="middle" rowspan="1" colspan="1">C<sub>cr</sub></th><th align="center" valign="middle" rowspan="1" colspan="1">C<sub>10th</sub></th></tr><tr><th colspan="2" align="center" valign="middle" rowspan="1">
<hr/></th><th colspan="2" align="center" valign="middle" rowspan="1">
<hr/></th></tr><tr><th colspan="2" align="center" valign="middle" rowspan="1">mL/min/1.73 m<sup>2</sup></th><th colspan="2" align="center" valign="middle" rowspan="1">mL/min/1.73 m<sup>2</sup></th></tr></thead><tbody><tr><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">92</td><td align="center" valign="top" rowspan="1" colspan="1">74</td><td align="center" valign="top" rowspan="1" colspan="1">1.23</td><td align="center" valign="top" rowspan="1" colspan="1">75</td><td align="center" valign="top" rowspan="1" colspan="1">73</td><td align="center" valign="top" rowspan="1" colspan="1">1.03</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">89</td><td align="center" valign="top" rowspan="1" colspan="1">68</td><td align="center" valign="top" rowspan="1" colspan="1">1.30</td><td align="center" valign="top" rowspan="1" colspan="1">74</td><td align="center" valign="top" rowspan="1" colspan="1">71</td><td align="center" valign="top" rowspan="1" colspan="1">1.04</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">32</td><td align="center" valign="top" rowspan="1" colspan="1">22</td><td align="center" valign="top" rowspan="1" colspan="1">1.44</td><td align="center" valign="top" rowspan="1" colspan="1">25</td><td align="center" valign="top" rowspan="1" colspan="1">24</td><td align="center" valign="top" rowspan="1" colspan="1">1.07</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">27</td><td align="center" valign="top" rowspan="1" colspan="1">11</td><td align="center" valign="top" rowspan="1" colspan="1">2.46</td><td align="center" valign="top" rowspan="1" colspan="1">16</td><td align="center" valign="top" rowspan="1" colspan="1">9</td><td align="center" valign="top" rowspan="1" colspan="1">1.87</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">33</td><td align="center" valign="top" rowspan="1" colspan="1">19</td><td align="center" valign="top" rowspan="1" colspan="1">1.80</td><td align="center" valign="top" rowspan="1" colspan="1">20</td><td align="center" valign="top" rowspan="1" colspan="1">19</td><td align="center" valign="top" rowspan="1" colspan="1">1.10</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">47</td><td align="center" valign="top" rowspan="1" colspan="1">37</td><td align="center" valign="top" rowspan="1" colspan="1">1.28</td><td align="center" valign="top" rowspan="1" colspan="1">40</td><td align="center" valign="top" rowspan="1" colspan="1">36</td><td align="center" valign="top" rowspan="1" colspan="1">1.10</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">7</td><td align="center" valign="top" rowspan="1" colspan="1">57</td><td align="center" valign="top" rowspan="1" colspan="1">32</td><td align="center" valign="top" rowspan="1" colspan="1">1.77</td><td align="center" valign="top" rowspan="1" colspan="1">38</td><td align="center" valign="top" rowspan="1" colspan="1">35</td><td align="center" valign="top" rowspan="1" colspan="1">1.07</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">8</td><td align="center" valign="top" rowspan="1" colspan="1">124</td><td align="center" valign="top" rowspan="1" colspan="1">93</td><td align="center" valign="top" rowspan="1" colspan="1">1.35</td><td align="center" valign="top" rowspan="1" colspan="1">120</td><td align="center" valign="top" rowspan="1" colspan="1">104</td><td align="center" valign="top" rowspan="1" colspan="1">1.15</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">9</td><td align="center" valign="top" rowspan="1" colspan="1">44</td><td align="center" valign="top" rowspan="1" colspan="1">33</td><td align="center" valign="top" rowspan="1" colspan="1">1.31</td><td align="center" valign="top" rowspan="1" colspan="1">38</td><td align="center" valign="top" rowspan="1" colspan="1">34</td><td align="center" valign="top" rowspan="1" colspan="1">1.11</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">10</td><td align="center" valign="top" rowspan="1" colspan="1">55</td><td align="center" valign="top" rowspan="1" colspan="1">39</td><td align="center" valign="top" rowspan="1" colspan="1">1.42</td><td align="center" valign="top" rowspan="1" colspan="1">46</td><td align="center" valign="top" rowspan="1" colspan="1">41</td><td align="center" valign="top" rowspan="1" colspan="1">1.12</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">11</td><td align="center" valign="top" rowspan="1" colspan="1">129</td><td align="center" valign="top" rowspan="1" colspan="1">84</td><td align="center" valign="top" rowspan="1" colspan="1">1.54</td><td align="center" valign="top" rowspan="1" colspan="1">87</td><td align="center" valign="top" rowspan="1" colspan="1">82</td><td align="center" valign="top" rowspan="1" colspan="1">1.05</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">12</td><td align="center" valign="top" rowspan="1" colspan="1">27</td><td align="center" valign="top" rowspan="1" colspan="1">14</td><td align="center" valign="top" rowspan="1" colspan="1">1.95</td><td align="center" valign="top" rowspan="1" colspan="1">11</td><td align="center" valign="top" rowspan="1" colspan="1">12</td><td align="center" valign="top" rowspan="1" colspan="1">0.97</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">13</td><td align="center" valign="top" rowspan="1" colspan="1">51</td><td align="center" valign="top" rowspan="1" colspan="1">27</td><td align="center" valign="top" rowspan="1" colspan="1">1.92</td><td align="center" valign="top" rowspan="1" colspan="1">33</td><td align="center" valign="top" rowspan="1" colspan="1">20</td><td align="center" valign="top" rowspan="1" colspan="1">1.65</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">14</td><td align="center" valign="top" rowspan="1" colspan="1">158</td><td align="center" valign="top" rowspan="1" colspan="1">124</td><td align="center" valign="top" rowspan="1" colspan="1">1.27</td><td align="center" valign="top" rowspan="1" colspan="1">138</td><td align="center" valign="top" rowspan="1" colspan="1">125</td><td align="center" valign="top" rowspan="1" colspan="1">1.10</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">15</td><td align="center" valign="top" rowspan="1" colspan="1">36</td><td align="center" valign="top" rowspan="1" colspan="1">28</td><td align="center" valign="top" rowspan="1" colspan="1">1.32</td><td align="center" valign="top" rowspan="1" colspan="1">33</td><td align="center" valign="top" rowspan="1" colspan="1">29</td><td align="center" valign="top" rowspan="1" colspan="1">1.13</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">16</td><td align="center" valign="top" rowspan="1" colspan="1">86</td><td align="center" valign="top" rowspan="1" colspan="1">55</td><td align="center" valign="top" rowspan="1" colspan="1">1.57</td><td align="center" valign="top" rowspan="1" colspan="1">65</td><td align="center" valign="top" rowspan="1" colspan="1">57</td><td align="center" valign="top" rowspan="1" colspan="1">1.13</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">17</td><td align="center" valign="top" rowspan="1" colspan="1">63</td><td align="center" valign="top" rowspan="1" colspan="1">42</td><td align="center" valign="top" rowspan="1" colspan="1">1.50</td><td align="center" valign="top" rowspan="1" colspan="1">38</td><td align="center" valign="top" rowspan="1" colspan="1">39</td><td align="center" valign="top" rowspan="1" colspan="1">0.96</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">18</td><td align="center" valign="top" rowspan="1" colspan="1">34</td><td align="center" valign="top" rowspan="1" colspan="1">13</td><td align="center" valign="top" rowspan="1" colspan="1">2.63</td><td align="center" valign="top" rowspan="1" colspan="1">20</td><td align="center" valign="top" rowspan="1" colspan="1">16</td><td align="center" valign="top" rowspan="1" colspan="1">1.23</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">19</td><td align="center" valign="top" rowspan="1" colspan="1">129</td><td align="center" valign="top" rowspan="1" colspan="1">49</td><td align="center" valign="top" rowspan="1" colspan="1">2.65</td><td align="center" valign="top" rowspan="1" colspan="1">54</td><td align="center" valign="top" rowspan="1" colspan="1">43</td><td align="center" valign="top" rowspan="1" colspan="1">1.27</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">20</td><td align="center" valign="top" rowspan="1" colspan="1">63</td><td align="center" valign="top" rowspan="1" colspan="1">55</td><td align="center" valign="top" rowspan="1" colspan="1">1.14</td><td align="center" valign="top" rowspan="1" colspan="1">57</td><td align="center" valign="top" rowspan="1" colspan="1">52</td><td align="center" valign="top" rowspan="1" colspan="1">1.09</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">21</td><td align="center" valign="top" rowspan="1" colspan="1">62</td><td align="center" valign="top" rowspan="1" colspan="1">43</td><td align="center" valign="top" rowspan="1" colspan="1">1.43</td><td align="center" valign="top" rowspan="1" colspan="1">47</td><td align="center" valign="top" rowspan="1" colspan="1">39</td><td align="center" valign="top" rowspan="1" colspan="1">1.21</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">22</td><td align="center" valign="top" rowspan="1" colspan="1">44</td><td align="center" valign="top" rowspan="1" colspan="1">19</td><td align="center" valign="top" rowspan="1" colspan="1">2.27</td><td align="center" valign="top" rowspan="1" colspan="1">23</td><td align="center" valign="top" rowspan="1" colspan="1">17</td><td align="center" valign="top" rowspan="1" colspan="1">1.34</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">23</td><td align="center" valign="top" rowspan="1" colspan="1">78</td><td align="center" valign="top" rowspan="1" colspan="1">33</td><td align="center" valign="top" rowspan="1" colspan="1">2.32</td><td align="center" valign="top" rowspan="1" colspan="1">47</td><td align="center" valign="top" rowspan="1" colspan="1">37</td><td align="center" valign="top" rowspan="1" colspan="1">1.26</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">24</td><td align="center" valign="top" rowspan="1" colspan="1">88</td><td align="center" valign="top" rowspan="1" colspan="1">32</td><td align="center" valign="top" rowspan="1" colspan="1">2.78</td><td align="center" valign="top" rowspan="1" colspan="1">38</td><td align="center" valign="top" rowspan="1" colspan="1">31</td><td align="center" valign="top" rowspan="1" colspan="1">1.22</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">25</td><td align="center" valign="top" rowspan="1" colspan="1">70</td><td align="center" valign="top" rowspan="1" colspan="1">49</td><td align="center" valign="top" rowspan="1" colspan="1">1.42</td><td align="center" valign="top" rowspan="1" colspan="1">58</td><td align="center" valign="top" rowspan="1" colspan="1">55</td><td align="center" valign="top" rowspan="1" colspan="1">1.05</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">(mean&#x000b1;SD)</td><td align="center" valign="top" rowspan="1" colspan="1">69&#x000b1;36</td><td align="center" valign="top" rowspan="1" colspan="1">44&#x000b1;27</td><td align="center" valign="top" rowspan="1" colspan="1">1.72&#x000b1;0.51</td><td align="center" valign="top" rowspan="1" colspan="1">50&#x000b1;31<xref ref-type="table-fn" rid="tfn3-kjim-8-1-28-6"><sup>*</sup></xref></td><td align="center" valign="top" rowspan="1" colspan="1">44&#x000b1;29</td><td align="center" valign="top" rowspan="1" colspan="1">1.17&#x000b1;0.20<xref ref-type="table-fn" rid="tfn3-kjim-8-1-28-6"><sup>*</sup></xref></td></tr></tbody></table><table-wrap-foot><fn id="tfn3-kjim-8-1-28-6"><label>*</label><p>p&#x0003c;0.001, compared with placebo.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t3-kjim-8-1-28-6" orientation="portrait" position="float"><label>Table 3.</label><caption><p>C<sub>cr</sub>/C<sub>10th</sub> at Various Levels of Renai Function during Placebo and Cimetidine Administration</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="2" colspan="1"/><th colspan="3" align="center" valign="middle" rowspan="1">C<sub>10th</sub>(mL/min/1.73 m<sup>2</sup>)</th></tr><tr><th align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;40(n=14)</th><th align="center" valign="middle" rowspan="1" colspan="1">40&#x02013;80(n=8)</th><th align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;80(n=3)</th></tr></thead><tbody><tr><td align="center" valign="top" rowspan="1" colspan="1">Placebo</td><td align="center" valign="top" rowspan="1" colspan="1">1.91&#x000b1;0.52</td><td align="center" valign="top" rowspan="1" colspan="1">1.53&#x000b1;0.47</td><td align="center" valign="top" rowspan="1" colspan="1">1.38&#x000b1;0.14</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Cimetidine</td><td align="center" valign="top" rowspan="1" colspan="1">1.22&#x000b1;0.25<xref ref-type="table-fn" rid="tfn6-kjim-8-1-28-6"><sup>**</sup></xref></td><td align="center" valign="top" rowspan="1" colspan="1">1.09&#x000b1;0.10<xref ref-type="table-fn" rid="tfn5-kjim-8-1-28-6"><sup>*</sup></xref></td><td align="center" valign="top" rowspan="1" colspan="1">1.10&#x000b1;0.04<xref ref-type="table-fn" rid="tfn5-kjim-8-1-28-6"><sup>*</sup></xref></td></tr></tbody></table><table-wrap-foot><fn id="tfn4-kjim-8-1-28-6"><p>Abbreviations as in <xref ref-type="table" rid="t1-kjim-8-1-28-6">Table 1</xref>.</p></fn><fn id="tfn5-kjim-8-1-28-6"><label>*</label><p>p&#x0003c;0.01,</p></fn><fn id="tfn6-kjim-8-1-28-6"><label>**</label><p>p&#x0003c;0.001: compared with placebo.</p></fn></table-wrap-foot></table-wrap></floats-group></article>